Dapagliflozin-Does Cost Make 4-Pillar Heart Failure Therapy Too Herculean a Labor for Medicine?

JAMA Cardiol. 2021 Aug 1;6(8):875-876. doi: 10.1001/jamacardio.2021.1448.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benzhydryl Compounds / therapeutic use
  • Glucosides* / therapeutic use
  • Heart Failure* / drug therapy
  • Humans

Substances

  • Benzhydryl Compounds
  • Glucosides
  • dapagliflozin